Talk:Azilsartan

This is the talk page for discussing improvements to the Azilsartan article.
This is not a forum for general discussion of the article's subject.

Put new text under old text. Click here to start a new topic.
New to Wikipedia? Welcome! Learn to edit; get help.

Article policies

Find medical sources: Source guidelines · PubMed · Cochrane · DOAJ · Gale · OpenMD · ScienceDirect · Springer · Trip · Wiley · TWL

Pharmacology Mid‑importance

	This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology articles
Mid	This article has been rated as Mid-importance on the project's importance scale.

Medicine Mid‑importance

	Medicine portal This article is within the scope of WikiProject Medicine, which recommends that medicine-related articles follow the Manual of Style for medicine-related articles and that biomedical information in any article use high-quality medical sources. Please visit the project page for details or ask questions at Wikipedia talk:WikiProject Medicine.MedicineWikipedia:WikiProject MedicineTemplate:WikiProject Medicinemedicine articles
Mid	This article has been rated as Mid-importance on the project's importance scale.

Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Azilsartan.

PubMed provides review articles from the past five years (limit to free review articles)
The TRIP database provides clinical publications about evidence-based medicine.
Other potential sources include: Centre for Reviews and Dissemination and CDC

Prodrug vs active ingredient

The article is for Azilsartan, but the structure shown is the prodrug Azilsartan medoxomil. I suggest that the image be changed to the active drug structure. -- The chemistds (talk) 13:59, 2 March 2011 (UTC)[reply]

That might be right, but the article seems a bit off. The refs are very sketchy. There are lots of trials but few published results except for PMID 20379769. LeadSongDog come howl! 03:20, 6 April 2011 (UTC)[reply]

That is right (see Sigma), I've exchanged structures and changed values in the drug box. --Cvf-ps (talk) 17:16, 17 January 2013 (UTC)[reply]

Rename the page to Azilsartan medoxomil?

The text of the page is mostly about the drug azilsartan medoxomil but many of the drugbox entries are for azilsartan. Should there be separate pages for Azilsartan and Azilsartan medoxomil? Should this page be renamed to Azilsartan medoxomil? Whywhenwhohow (talk) 17:22, 9 March 2020 (UTC)[reply]

Doc James (talk · contribs) What are your thoughts? Whywhenwhohow (talk) 04:52, 26 March 2020 (UTC)[reply]

Remark: Not sure whether we have a policy on this (we do for salts: the article is called Diclofenac, not Diclofenac sodium), but the same question applies to candesartan cilexetil. --ἀνυπόδητος (talk) 08:48, 26 March 2020 (UTC)[reply]

I am generally in favor of keeping the prodrug and drug together especially for obscure names. We need them together to properly distinguish them anyway. If there were a bunch of salts than maybe, but I am only seeing one here. Doc James (talk · contribs · email) 12:56, 26 March 2020 (UTC)[reply]